Syntal Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Syntal Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,725	Closed	-$1.07M	–	143
2019 Q3	$1.07M	Hold	10,725	–	–	0.28%	84
2019 Q2	$1.17M	Buy	+10,725	New	+$1.14M	0.25%	91
2014 Q2	–	Sell	-32,175	Closed	-$25.4M	–	230
2014 Q1	$25.4M	Buy	+32,175	New	+$2.68M	14.84%	1

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Syntal Capital Partners's IBB Position: Q4 2019 in Review

Syntal Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 10,725 shares — an estimated $1.07M sold.

Syntal Capital Partners first reported a position in IBB in Q1 2014 and held it in 3 quarters. The position peaked at $25.4M in Q1 2014. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

Syntal Capital Partners reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
Syntal Capital Partners sold 10,725 iShares Biotechnology ETF shares in Q4 2019, an estimated $1.07M.
Syntal Capital Partners first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 3 quarters.
Syntal Capital Partners's iShares Biotechnology ETF position peaked at $25.4M in Q1 2014.
710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Syntal Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.